|
|
|
|
|
|
| Related Keyword：招股 , 入場費 , 輕松健康 , 諾比侃 , 翰思艾泰 |
| Related Concept：翰思艾泰諾比侃輕松健康 , 招股入場費 , 黃金明年 , 翰思艾泰今起招股 |
| |
| AI企業諾比侃擬通過香港IPO籌資5,000萬美元 ＠ 2025-12-16T |
| 諾比侃人工智慧科技(Nuobikan Artificial Intelligence Technology)計劃通過在香港上市籌集約5,000萬美元，加入了在新年前夕競相赴港上市的中國公司... |
| Keyword：招股 |
| Concept：翰思艾泰諾比侃輕松健康 , 招股入場費 |
| 輕松健康集團受惠行業快速增長 評論 - 評論內容Commentary Content ＠ 2025-12-16T |
| 中國互聯網醫療產業正蓬勃發展，藉助5G、大數據、AI 等技術，已從單純的線上掛號問診，延伸至全流程的疾病管理、在線購藥、醫保支付、遠程監護等，... |
| Keyword：招股 入場費 |
| Concept：黃金明年 |
| 新股上市｜B仔股翰思艾泰（03378）招股入場費3233元，七家基投認購逾9000萬元 ＠ 2025-12-16T |
| 《經濟通通訊社15日專訊》翰思艾泰－B（03378）今日至周四（18日）招股，計劃全球發售1832.1萬股H股，當中約10%在港發售，其余作國際發售，每股作價介乎28元... |
| Keyword：招股 入場費 輕松健康 |
| Concept：翰思艾泰諾比侃輕松健康 , 招股入場費 |
| 新股上市｜AI科技公司諾比侃（02635）招股入場費5354元，上半年淨利潤跌21% ＠ 2025-12-16T04: |
| 《經濟通通訊社15日專訊》人工智能科技公司諾比侃（02635）今日至周四（18日）招股，計劃全球發售378.66萬股H股，當中約10%在港發售，其余作國際發售，... |
| Keyword：招股 入場費 諾比侃 翰思艾泰 |
| Concept：翰思艾泰今起招股 |
|
|
|
|
|
|
|
| Disclaimer :
In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.
|
|